Needham & Company
-
Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
-
Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
-
Aerpio Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference

